Advertisement

Topics

CTI BioPharma closes $65mm public offering

19:41 EST 9 Feb 2018 | Elsevier Business Intelligence

CTI BioPharma Corp. (treatments for blood cancers) netted $65mm through a public offering of 23mm common shares (including th...

Original Article: CTI BioPharma closes $65mm public offering

NEXT ARTICLE

More From BioPortfolio on "CTI BioPharma closes $65mm public offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...